Regulation of Cbfa1 expression by total flavonoids of Herba epimedii

被引：50

作者：

Qian, GF

Zhang, XZ

Lu, LX

Wu, XJ

Li, SM

Meng, J

机构：

[1] Tongji Univ, Tongji Hosp, Dept Endocrinol, Shanghai 200065, Peoples R China

[2] Tongji Univ, Sch Med, Dept Biochem, Shanghai 200092, Peoples R China

[3] Univ Giessen, Inst Indoor & Environm Toxicol, D-35385 Giessen, Germany

来源：

ENDOCRINE JOURNAL | 2006年 / 53卷 / 01期

关键词：

total flavonoids of Herba epimedii; core binding factor alpha 1; osteoporosis;

D O I：

10.1507/endocrj.53.87

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Core binding factor alpha 1 (Cbfa1) is a member of the runt family of transcription factors, which appears to play a pivotal role in regulating the differentiation of osteoblastic precursors and the activity of mature osteoblasts. Total flavonoids of Herba epimedii (HEF) is a recognized bone anabolic agent, but there is lack of reports on the modulation of Cbfa1 expression by HEF. Here we investigated the effect of HEF on Cbfa1 expression in the bone of ovariectomized (OVX) rats. HEF could increase the expression of Cbfa1 mRNA in the bone of ovariectomized rats in a dose-dependent manner. Furthermore, the high dose HEF (160 mg/kg) administered for 12 weeks in vivo stimulated osteocalcin expression. These findings Suggest that Cbfa1 is required for mediating the anabolic effects of HEF.

引用

收藏

页码：87 / 94

页数：8

相关论文

共 21 条

[1]

BANERJEE U, 1997, LOOP TR RESTRUCT COM, V3, P1

[2] Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems [J].

Bustin, SA .

JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2002, 29 (01) :23-39

[3] Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis [J].

Dang, ZC ;

Van Bezooijen, RL ;

Karperien, M ;

Papapoulos, SE ;

Löwik, CWGM .

JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (03) :394-405

[4] Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation [J].

Ducy, P ;

Zhang, R ;

Geoffroy, V ;

Ridall, AL ;

Karsenty, G .

CELL, 1997, 89 (05) :747-754

[5] A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development [J].

Ducy, P ;

Starbuck, M ;

Priemel, M ;

Shen, JH ;

Pinero, G ;

Geoffroy, V ;

Amling, M ;

Karsenty, G .

GENES & DEVELOPMENT, 1999, 13 (08) :1025-1036

[6] Transactivation of core binding factor α1 as a basic mechanism to trigger parathyroid hormone-induced osteogenesis [J].

Fujita, T ;

Fukuyama, R ;

Izumo, N ;

Hirai, T ;

Meguro, T ;

Nakamuta, H ;

Koida, M .

JAPANESE JOURNAL OF PHARMACOLOGY, 2001, 86 (04) :405-416

[7] Isolation and characterization of the distal promoter region of mouse Cbfa1 [J].

Fujiwara, M ;

Tagashira, S ;

Harada, H ;

Ogawa, S ;

Katsumata, T ;

Nakatsuka, M ;

Komori, T ;

Takada, H .

BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1446 (03) :265-272

[8] Differentiation of human marrow stromal precursor cells: Bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation [J].

Gori, F ;

Thomas, T ;

Hicok, KC ;

Spelsberg, TC ;

Riggs, BL .

JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (09) :1522-1535

[9] Hormonal therapies and osteoporosis [J].

Jerome, CP .

ILAR JOURNAL, 2004, 45 (02) :170-178

[10] Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts [J].

Komori, T ;

Yagi, H ;

Nomura, S ;

Yamaguchi, A ;

Sasaki, K ;

Deguchi, K ;

Shimizu, Y ;

Bronson, RT ;

Gao, YH ;

Inada, M ;

Sato, M ;

Okamoto, R ;

Kitamura, Y ;

Yoshiki, S ;

Kishimoto, T .

CELL, 1997, 89 (05) :755-764